The Efficacy and Safety of PEG-rhG-CSFPegylated Recombinant Human Granulocyte Colony Stimulating Factor)in Patients With Breast Cancer Who Were Treated With Intensive Chemotherapy
Latest Information Update: 05 Aug 2022
At a glance
- Drugs Pegfilgrastim (Primary)
- Indications Breast cancer
- Focus Therapeutic Use
- 16 Jan 2019 Status changed from recruiting to completed.
- 02 Nov 2016 New trial record